Kristian G. AndersenGeverifieerd account

This initiative could lead to developing countries being more advanced than developed ones (e.g. the US) by incorporating rapid, point-of-care pathogen sequencing.

Absolutely. It’s the deployment and availability of sequencing and reagents that is key however, not the software

Agreed. Also, for the software I have a hard time seeing what's new here? It's all pre-existing tools wrapped into a website (that I can't access). E.g. Taxonomer from IDbyDNA has been available for years (and is very fast with immediate results): https://www.taxonomer.com/ 

Yeah I note this in the piece. They argue that the differences are in how intuitive the front end is and how robust the back end is. But I think the key diff is: for better or worse, this is the one that funders are backing.

No particular issue with IDseq concetually but it would be a terrible mistake to focus on any particular software package or method in such a rapidly developing and unvalidated field ...

Yeah. As for how intuitive it is, I'll wait until I gain access to pass judgment. The main issue on the front end though is *interpretation*, not presentation. Mainly because of misclassifications and contaminants upstream in the pipeline - far from trivial to do.